Evaluating how long venous leg ulcers stay closed after treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the durability of closure for venous leg ulcers in patients who previously achieved closure during the THOR trial. It compares the recurrence rates of ulcers in subjects treated with Intact Fish Skin Graft (IFSG) plus standard of care against those treated with standard of care alone. By following up on these patients, the study seeks to provide insights into the long-term effectiveness of the treatments used in the THOR trial.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.

Exclusion Criteria:

* 1\. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.

Where it's running

• Serena Group
  Monroeville, Pennsylvania, United States Recruiting

Study contacts

• Study coordinator: Bennett Rogers
• Email: brogers@serenagroups.com
• Phone: 888-960-1343

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

  This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

  Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

• GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study

  This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.

  Recruiting at 4 sites W.L.Gore & Associates · Darien, Connecticut and 3 other locations · NCT07538609

• Evaluating new treatments for nonhealing diabetic foot and venous leg ulcers.

  This study is testing whether new treatments for stubborn diabetic foot and leg ulcers can help people heal better when combined with standard care compared to just standard care alone.

  Recruiting Phase 4 Tiger Biosciences, LLC. · Monroeville, Pennsylvania · NCT06826339

• New gel treatment for venous leg ulcers

  This study is testing a new gel treatment for people with stubborn venous leg ulcers to see if it helps them heal better than just the usual care.

  Recruiting at 5 sites Phase 3 TR Therapeutics · Jacksonville, Florida and 11 other locations · NCT06707103

• Tissue Repair Gel for treating Venous Leg Ulcers

  This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.

  Recruiting at 24 sites Phase 3 TR Therapeutics · Tucson, Arizona and 32 other locations · NCT06707090

• Using fish skin grafts to treat nonhealing venous leg ulcers

  This study is testing whether using fish skin grafts along with regular treatment can help people with stubborn leg ulcers heal better than just using regular treatment alone.

  Recruiting Phase 4 Kerecis Ltd. · Monroeville, Pennsylvania · NCT06693570

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.